Spears Abacus Advisors LLC Abbott Laboratories Transaction History

Spears Abacus Advisors LLC

$4.64 Billion
Q3 2025

A detailed history of Spears Abacus Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 561,928 shares of ABT stock, worth $73.1 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares

561,928

Previous 520,566 7.95%

Holding current value

$73.1 Million

Previous $70.8 Million 6.3%

% of portfolio

1.62%

Previous 1.63%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$120.51 - $136.62 $4.98 Million - $5.65 Million	41,362 Added 7.95%	561,928 $75.3 Million
Q2 2025 Aug 14, 2025	SELL	$123.95 - $138.08 $2.4 Million - $2.67 Million	-19,357 Reduced 3.59%	520,566 $70.8 Million
Q1 2025 May 14, 2025	SELL	$111.1 - $140.22 $4.18 Million - $5.27 Million	-37,617 Reduced 6.51%	539,923 $71.6 Million
Q4 2024 Feb 12, 2025	SELL	$111.93 - $119.39 $1.45 Million - $1.55 Million	-12,968 Reduced 2.2%	577,540 $65.3 Million
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $23.5 Million - $27.8 Million	235,040 Added 66.12%	590,508 $67.3 Million

Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $22,865 - $25,523	227 Added 0.06%	355,468 $36.9 Million
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $38.3 Million - $42.3 Million	350,066 Added 6764.56%	355,241 $40.4 Million
Q3 2023 Nov 21, 2023	BUY	$95.53 - $114.62 $1,910 - $2,292	20 Added 0.39%	5,175 $501,000
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $50,390 - $56,145	-500 Reduced 8.84%	5,155 $561,000
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $13,560 - $15,961	140 Added 2.54%	5,655 $572,000
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $69,298 - $81,298	729 Added 15.23%	5,515 $605,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $1,257 - $1,456	-13 Reduced 0.27%	4,786 $463,000
Q2 2022 Aug 08, 2022	BUY	$102.07 - $123.37 $2,245 - $2,714	22 Added 0.46%	4,799 $521,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $146,145 - $178,946	1,265 Added 36.02%	4,777 $672,000
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $105,790 - $124,530	1,000 Added 39.81%	3,512 $407,000
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $51,263 - $60,396	-471 Reduced 15.79%	2,512 $301,000
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $28,980 - $31,579	-276 Reduced 8.47%	2,983 $327,000
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $298,654 - $362,694	3,259 New	3,259 $355,000

Others Institutions Holding ABT

# of Institutions

3,652

Shares Held

1.38B

Call Options Held

10.4M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spears Abacus Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spears Abacus Advisors LLC with notifications on news.

Account

Spears Abacus Advisors LLC Abbott Laboratories Transaction History